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Abstract
2q  .The ryanodine-sensitive Ca -release channel of the canine diaphragm sarcoplasmic reticulum SR was characterized
w3 xusing biochemical assays and the planar lipid bilayer technique. Diaphragm SR membranes have a H ryanodine-binding
 .  .capacity B of 1.2 pmolrmg protein and a binding affinity K of 6.3 nM. The conductance of the native channel wasmax D
330 pS in 50 mMr250 mM transrcis CsCH SO and was reduced to 71 pS by 10 mM Ca2q trans. The Ca2q-release3 3
channel was purified as a 400 kDa protein on SDS-PAGE and displayed a conductance of 715 pS in 200 mM KCl. The
native and purified Ca2q channels were activated by micromolar Ca2q and ATP and inhibited by Mg2q, ryanodine and
ruthenium red. Although diaphragm muscle contraction was shown to depend on extracellular Ca2q like cardiac muscles,
we provide evidence that the diaphragm SR Ca2q-release channel may be classified as a skeletal ryanodine receptor
w3 xisoform. First, the IC for H ryanodine binding was in the same range as estimated for skeletal SR, with 20 nM. Second,50
the channel was maximally activated by 10–30 mM cytoplasmic Ca2q and inhibited at higher concentrations. Third,
ryanodine binding to the diaphragm SR was less sensitive to Ca2q than cardiac SR, with EC values of 50 and 1 mM,50
2q w3 xrespectively. Finally, Ca -release activity and H ryanodine binding capacity of the diaphragm and skeletal SR were
similarly more sensitive to Mg2q than cardiac SR. Together, these results suggest a predominantly skeletal-type of
excitation-contraction coupling in the diaphragm. q 1997 Elsevier Science B.V.
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1. Introduction
In striated muscle cells, the sarcoplasmic reticulum
 .SR is responsible for the release and uptake of
2q  .Ca during excitation-contraction coupling ECC
w x 2q1,2 . The release of Ca from the SR is mediated
by Ca2q-release channels, also known as ryanodine
 .receptors RyRs , because they bind to the plant
w xalkaloid with high affinity and specificity 3,4 . Three
structurally related RyRs have been identified in
 .mammalian tissues: a skeletal muscle RyR isoform1
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w x  . w x5 , a cardiac muscle RyR isoform 6,7 and a third2
 . w xisoform RyR first detected in the brain 8 . All3
three isoforms have structural and functional features
in common. They migrate through sucrose gradients
with an apparent sedimentation coefficient of ;30 S
w x9 and they display a major polypeptide band of
w x;400 kDa on SDS-polyacrylamide gels 10–12 .
The functional channel is formed by four of these
w x;400 kDa proteins 13 , which have been shown to
correspond to the ‘foot proteins’ that span the gap
w xbetween the SR membrane and the T-tubule 6,14 .
The very large subunits presumably allow a complex
pattern of regulation by various endogenous and ex-
ogenous effector molecules. The cardiac and skeletal
Ca2q-release channels are activated by micromolar
Ca2q, ATP, caffeine and nanomolar ryanodine and
they are inhibited by Mg2q, ruthenium red and mi-
w xcromolar ryanodine 15 . A number of differences
however attest that the RyR isoforms are not equiva-
lent. They are expressed by three different genes and
they share only 67% amino acid sequence identity
w x8,16 . The cardiac and skeletal isoforms differ in
2q w xtheir sensitivity to cytoplasmic Ca 17–20 and to
phosphorylation by calmodulin- and cyclic AMP-de-
w xpendent protein kinases 21,22 . Finally, two different
mechanisms of RyR activation have been postulated
for skeletal and cardiac muscles: RyRs ‘physically’
coupled to voltage-dependent dihydropyridine-
2q  .sensitive Ca channels DHPRs of the sarcolemmal
w xT-tubules 23 and RyRs activated by an influx of
2q w xextracellular Ca through DHPRs 24,25 .
Although the diaphragm has been classified as a
striated skeletal muscle, this tissue shares contractile
properties with both the cardiac and non-respiratory
skeletal muscles. Like the heart, the diaphragm con-
tracts rhythmically for life. On the other hand, it
responds to neural drive as well as work load very
w xmuch like skeletal muscles 26 . Despite numerous
studies dealing with the contractile properties of nor-
w xmal and dystrophic diaphragm fibers 27–30 , little is
known of the electrophysiological properties of their
SR membrane system. Muscle contraction was shown
2q w xto rely on extracellular Ca 31,32 and to be altered
w xby ryanodine 33,34 . Recent studies have reported
the functional characteristics of the SR Ca2q pump
w x35 and the SR conductance for monovalent ions
w x 2q36 . In this study, we investigated the Ca -releasing
properties of the diaphragm SR using biochemical
assays and single-channel recordings from SR vesi-
cles or purified ryanodine receptors incorporated into
planar lipid bilayers.
2. Materials and methods
2.1. Materials
 X .AMP adenosine 5 -monophosphate , ATP
 X .adenosine 5 -triphosphate , CaCl , cesium methane-2
 .sulfonate CsCH SO , dithio-threitol, MgSO and3 3 4
protease inhibitors were obtained from Sigma St.
.Louis, Mo . Ruthenium red was bought from Te-
  .rochem, AEBSF 4- 2-aminoethyl -benzenesulfonyl
.fluoride from Boehringer Mannheim and phospho-
 .lipids from Avanti Polar-lipids Alabaster, Al .
w3 xH ryanodine was purchased from New England Nu-
 .clear NEN-Dupont Canada and cold ryanodine was
kindly provided by Dr. L. Ruest, Department of
Chemistry, University of Sherbrooke, Canada. Deion-
ized water from a Millipore Ro-Milli-Q-UF system
 2.18"0.2 MVrcm was used to prepare all buffer
solutions. All other chemicals were commercial prod-
ucts of analytical grade.
2.2. Preparation of sarcoplasmic reticulum ˝esicles
and purified ryanodine receptors
Microsomal fractions enriched in SR vesicles were
prepared from canine diaphragm according to
w xRousseau et al. 37 . Briefly, canine diaphragms were
homogenized and centrifuged at 7,500 rpm 6,000=
.  .g for 20 min at 48C in Tris–maleate buffer pH 6.8
in the presence of protease inhibitors. The super-
natant was filtered and centrifuged at 33,000 rpm
 .90,000=g at 48C for 1 h 20 min. The pellet was
 .resuspended in K-PIPES buffer pH 7.0 and the
membrane vesicles were separated by ultracentrifuga-
tion at 120,000=g on a 25–45% sucrose gradient.
Sucrose fractions were analyzed for their protein
w3 xcontent and H ryanodine binding activity. Protein
concentration was determined by the Lowry method
w x38 using bovine serum albumin as a standard.
w3 xH ryanodine binding assays were performed using a
w xprocedure originally described by Hawkes et al. 39
w xand routinely used in our laboratory 40 . Briefly,
( )M. Picher et al.rBiochimica et Biophysica Acta 1328 1997 243–260 245
 .microsomal fractions 100 mg collected from the
sucrose gradient were incubated 90 min at 378C in
the presence of 1 M NaCl, 5 mM AMP, 50 mM free
2q w3 xCa , 20 mM MOPS and 5 nM H ryanodine. The
mixture was then centrifuged twice and pellet ra-
dioactivity was determined by liquid scintillation.
w3 xSpecific H ryanodine binding was calculated by
 w3 xsubtracting nonspecific binding 5 nM H ryanodine
. q5 mM ryanodine from total binding 5 nM
w3 x .H ryanodine . The saturation curves were fitted with
 .the following equation ysaxr bqx describing
the Michaelis–Menten formalism where a is the
 .maximum value B and b the dissociation con-max
 .stant K . The displacement curves were obtainedD
in the presence of increasing concentrations of unla-
belled ryanodine. The mean values obtained from the
displacement experiments were fitted with the follow-
 .   . b.ing equation: ys ayd r 1q xrc qd, where
a is the asymptotic maximum, b is the slope, c is the
 .value of inflection half displacement and d is the
asymptotic minimum.
The most enriched fraction in ryanodine receptors,
recovered in 40% sucrose, was used to purify the SR
Ca2q-release channel. The microsomal fraction was
w3 xincubated with H ryanodine, solubilized in 1%
CHAPS and 3% azolectine and finally subjected to
 .centrifugation in a linear 5–25% wrv sucrose den-
w xsity gradient 12 . The sucrose fractions were again
w3 xanalyzed for their H ryanodine binding activity and
protein content.
2.3. Immunoblot assays
Microsomes were electrophoresed on 6% SDS-
PAGE gels and transferred to nitrocellulose mem-
branes at 30 V overnight at 48C. The nitrocellulose
membranes were washed 15 min in 200 mM Tris, 1.4
 .M NaClq0.1% Tween 20, pH 7.6 TBS-T , blocked
with 5% non-fat dry milk in TBS-T and incubated
with polyclonal antibodies raised against the skeletal
ryanodine receptor isoform RyR kindly provided by1
.Dr. Meissner, University of North Carolina . The
membranes were incubated with donkey anti-rabbit
IgG secondary antibodies coupled to horseradish1
 .  .peroxidase HRP Amersham 1 h at 238C and then
detected with the HRP-precipitating reagent Harlan
.Bioproducts .
Fig. 1. Normalized equilibrium binding curve for the Ca2q-re-
w3 xlease channel marker H ryanodine followed by Scatchard analy-
 .sis and displacement experiments. A Saturation curve represent-
ing the mean of five independent determinations using increasing
concentrations of radioactive ligand. Values were expressed in %
 .of the maximum binding capacity B . Inset: Typical Scatchardmax
 .  . w3 xanalysis of the bound B over boundrfree BrF H ryanodine.
K and B values were 6.3 nM and 1.06 pmolrmg of protein,d max
 . w3 xrespectively. B Displacement of H ryanodine bound to its
receptor by unlabelled ryanodine. Each assay contained 5 nM
w3 xH ryanodine, 100 mg of protein and increasing concentrations
of cold ryanodine from 1 nM to 10 mM. Percentage of
w3 xH ryanodine bound was plotted as a function of unlabelled
ryanodine concentration. As the concentration of ryanodine in-
creases, the quantity of tritiated ryanodine bound to the Ca2q-re-
 .lease channel decreases. The data shown are means "SEM
from five similar experiments performed in triplicate on various
preparations. Curve fitting attests that the data can be described
by an equation assuming a single high affinity binding site.
( )M. Picher et al.rBiochimica et Biophysica Acta 1328 1997 243–260246
2.4. Bilayer formation and ˝esicle fusion
 .The planar lipid bilayers PLB were formed at
room temperature from a lipid mixture containing
phosphatidylethanolamine, phospha-tidylserine and
w xphosphatidylcholine in a ratio of 3:2:1 37 . The final
lipid concentration was 25 mgrml dissolved in de-
cane. A 250 mm diameter hole, drilled in a Delrin
cup, was pretreated with the same lipid mixture
dissolved in chloroform. Using a Teflon stick, a drop
of the decane lipid mixture was gently spread across
the aperture in order to obtain an artificial membrane.
Membrane thinning was assayed by applying a trian-
gular wave test pulse. Typical capacitance values
were 150–300 pF. The chambers on either side of the
 .membrane were designated as cis cytoplasmic and
 .trans luminal . Aliquots of SR vesicles or purified
 .ryanodine receptor complexes 30–60 mg of protein
were added to the cis chamber in close proximity to
the bilayer. In the case of SR vesicles, the chambers
contained 50 mMr250 mM trans r cis cesium
 .methanesulfonate CsCH SO , plus symmetrical 103 3
2q mM free Ca 109 mM CaCl q100 mM Tris–2
.EGTA and 20 mM Tris–HEPES pH 7.4, unless
specified otherwise. The use of Tris and HEPES as
large impermeant cations and anions eliminated cur-
rents through Kq and Cly channels that are present
in native SR vesicles and become incorporated into
2q w xthe PLB along with the Ca -release channel 41 .
The fusions were either spontaneous, or facilitated by
w xapplying positive potentials across the bilayer 42 .
The purified ryanodine receptors were fused in sym-
metrical 200 mM KCl, plus 10 mM free Ca2q and 20
mM Tris–HEPES pH 7.2 and 2 mM ATP cis, unless
specified otherwise. Free Ca2q concentrations were
calculated using an apparent stability constant of
y7  .1.543=10 pH 7.4 for Ca–EGTA buffers and
w xcomputer programs published by Fabiato 43 , and
verified experimentally with a Ca2q electrode
 .KWIKCAL-WPI, Sarasota, FL as previously de-
w xscribed 44,45 .
2.5. Recording instrumentation and statistical
analyses
Command voltages were applied to the PLB
through Ag–AgCl electrode pellets connected to the
chambers via 2 M KCl-fritted glass bridges MERE2-
.WPI . The low impedence electrodes are very stable,
they have minimized junction potentials and variabil-
ity with time. The currents were recorded using a low
 . noise amplifier Dagan 3900 , filtered cut-off fre-
.quency 5 kHz and recorded on a digital audio tape
recorder through a pulse code modulation device 75
.ES-SONY, Unitrade . The currents were simultane-
ously displayed on-line on a chart recorder DASH II
. MT, Astro Med. and an oscilloscope Kikusui,
.5020A . Current recordings were played back, fil-
tered at 550 Hz with an 8-pole Bessel filter, sampled
at 2 kHz for storage and analysed on an IBM Pen-
tium computer using an Axotape program and the
interface from Axon-Instrument. The open probabil-
 .ity values P were determined from data stored ino
60 to 120 s duration files unless specified otherwise
and the half-threshold discriminator method was used.
Applied voltages were defined with respect to the
trans chamber, which was held at virtual ground.
Average values were given as means"standard error
 .of the mean SEM . Regression curves and curve-fit-
tings were performed using the Windows version of
the Sigma Plot program from Jandel Scientific.
2q  .Fig. 2. Biophysical properties of the native diaphragm SR Ca -release channel. A Steady state currents of a single channel recorded at
2q  .various holding potentials in 50r250 mM transrcis CsCH SO , plus 10 mM free Ca 109 mM CaCl q100 mM EGTA , 20 mM3 3 2
 .  .Tris–HEPES pH 7.4 and 2 mM Na ATP cis. Triangles on the right indicate the zero-current level. B Mean "SEM currentrvoltage2
 .  .  .relationships ns4 in 50r250 mM % and 250r250 mM l transrcis CsCH SO : the mean channel conductances were 332"243 3
 .pS and 298"19 pS and the reversal potentials were y31.5"3.2 mV and 0 mV, respectively. C Currentrvoltage curves in 50r250
2q  .mM transrcis CsCH SO , 10 mM free Ca , 20 mM Tris–HEPES pH 7.4 and 2 mM Na ATP cis, showing modifications in the3 3 2
 .  . 2qunitary conductance upon addition of 5 mM ‘ or 10 mM I Ca in the trans chamber. Unitary conductances in 10 mM, 5 and 10
mM Ca2q trans were 421 pS, 364 pS and 382 pS in the positive voltage range, and 225 pS, 125 pS and 71 pS in the negative voltage
range, respectively.
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3. Results
3.1. Characterization of the diaphragm SR membrane
˝esicles
Diaphragm cell membranes were separated on a
25–45% step sucrose gradient and characterized us-
w3 xing H ryanodine as a specific ligand for the SR
2q w xCa -release channel 7,39,46 . The most enriched
fraction in ryanodine receptors, which was recovered
w xin 40% sucrose 36 , was used in all biochemical and
biophysical experiments. The affinity of the di-
2q w3 xaphragm SR Ca -release channel for H ryanodine
was evaluated under optimum conditions: high salt
 . 2q concentration 1 M NaCl , micromolar free Ca 50
.  . w xmM and millimolar nucleotides 5 mM AMP 17 .
w3 xH ryanodine binding was studied with concentra-
tions in the nanomolar range in order to address only
2q  .Fig. 3. Gating properties of the diaphragm SR Ca -release channel. A Steady state currents of two channels recorded at a holding
2q potential of q60 mV in 50r250 mM transrcis CsCH SO , 20 mM Tris–HEPES, 10 mM free Ca 109 mM CaCl q100 mM3 3 2
.EGTA pH 7.4. Open triangles above the traces indicate abrupt changes in gating, and filled triangles on the right indicate the
 .zero-current level of the two channels. B Steady state current of a single channel recorded under the same conditions. Open triangles on
the right indicate subconductance levels at 1r4, 1r2 and 3r4 of the conductance of the fully open state, and filled triangles indicate the
zero-current level.
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the high-affinity binding sites. Fig. 1A shows that the
w3 xdiaphragm SR binds H ryanodine in a saturable
manner, with threshold and optimal concentrations of
1 and 50 nM, respectively. Scatchard analysis yields
 .a straight line with a dissociation constant K ofD
 .6.3 nM and maximum binding value B of 1.2max
 .pmolrmg of protein Fig. 1A, inset . In cardiac and
skeletal muscles, B values were reported in themax
range of 1 to 10 pmolrmg protein and 8 to 23
w xpmolrmg protein, respectively 13,21,47–50 . Fig.
1B indicates that increasing concentrations of unla-
 .belled ryanodine 1 nM to 10 mM displaced
w3 xH ryanodine from its binding sites. Considering
14% non-specific binding, the concentration of unla-
belled ryanodine needed to displace 50% of
w3 x  .H ryanodine IC was estimated to be 20 nM.50
This value is similar to those reported for skeletal SR
w x  .10 , but higher than the IC 5.2 nM reported for50
w xcardiac SR 40 .
3.2. Biophysical properties of the nati˝e
Ca2q-release channel
The experimental approach used to study the activ-
ity of the native diaphragm SR Ca2q-release channel
involved the incorporation of SR vesicles into planar
 .lipid bilayers PLB . Fig. 2A shows typical single-
channel current fluctuations in 50r250 mM transrcis
CsCH SO , activated by symmetrical 10 mM free3 3
Ca2q and 2 mM ATP cis. Under these conditions,
Csq is the permeant ion which flows from the cis to
the trans chamber at voltages more positive than the
 .reversal potential y31.5 mV . For potentials more
negative than y31.5 mV, currents are shown as
downward deflections.
Fig. 2B presents currentrvoltage relationships
recorded in 250r250 mM or 50r250 mM transrcis
CsCH SO . The mean slope conductance of the di-3 3
aphragm channel was 317"21 pS, which is less than
w xthe values reported for cardiac 51–53 and skeletal
w x  . q54,55 channels 400–525 pS in 250 mM Cs . In
asymmetrical buffer systems, the reversal potential
was shifted toward negative voltages, which argues in
favor of a Csq selectivity with respect to CH SOy.3 3
The relative permeability of the diaphragm channel to
monovalent and divalent cations was assessed in
q w 2qx50r250 mM transrcis Cs with increasing Ca
 . 2qtrans Fig. 2C . Addition of millimolar Ca to the
trans chamber resulted in a deviation from the Ohmic
currentrvoltage relationship that shifted the reversal
potential toward more positive potentials. At positive
potentials, the channel continued to conduct Csq ions
from the cis to the trans chamber in the presence of
the two ionic species, due to the asymmetrical distri-
bution of the Ca2q ions. In the negative voltage
range, the conductance was reduced to 71 pS by 10
mM Ca2q, indicating that Ca2q was competing with
Csq for the pore. Similar conductances were recorded
2q  .with 50 mM Ca trans 70–75 pS for the cardiac
w x SR channel 7,14,56 , but higher values 100–120
. w xpS were obtained for the skeletal channel 12,37,54 .
A permeability ratio of P 2qrP q of 14 wasCa Cs
w x w xestimated from the field equation 57 , where x and
w x qy correspond to the concentrations of Cs and
Ca2q, while z, F, R and T have their usual meaning.
 .This value is in the same range 10–30 as reported
w xfor the cardiac channel 20,51,58 .
2 yz EFr RT ..P F y y y ex i o2s z E yz EFr RT ..P RT 1yey
2 yz EFr RT ..F x y x ei o2= z E yz EFr RT ..RT 1ye
Most channels exhibited stationary gating proper-
ties composed of both long and short-lived events.
About 15% of the channels underwent abrupt changes
 .in gating behavior several times per minute Fig. 3A .
Similar mode switching behaviors were reported for
w xcardiac and skeletal SR RyRs 18,20,58,59 . Subcon-
ductance levels at 1r4, 1r2 and 3r4 of the conduc-
tance of the fully open state were also reported in
 .10% of the recordings Fig. 3B , as previously re-
w x w xported for skeletal 54,60,61 and cardiac 56 SR
Ca2q-release channels. Rapid flickering and subcon-
ductance levels at multiples of 25% of maximum
have been suggested to reflect the loss of a regulatory
 .protein called FK506-binding proteins FKPBs dur-
w xing the purification of SR membranes or RyRs 57 .
3.3. Calcium sensiti˝ity of the Ca2q-release channel
The effect of cytoplasmic Ca2q on the activity of
the native channel was assayed under steady state
conditions in 50r250 mM transrcis CsCH SO .3 3
Fig. 4A shows the current fluctuations of a single
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channel in the presence of increasing concentrations
2q  .of free Ca . The open probability P of the chan-o
2q  .nel was very low in 1 mM Ca P s0.05 , charac-o
terized by short open events. The channel was maxi-
2q  .mally activated by 10 mM Ca P s0.80 , ando
was gradually inactivated at higher concentrations, to
display only spike-like openings in 1 mM Ca2q
 .P s0.09 . Fig. 4 also indicates that the channelo
unitary conductance was not affected by successive
changes in Ca2q concentration. Fig. 4B summarizes
the relationship between cytoplasmic Ca2q and the
P of the channel. Activity threshold was recordedo
with 1 mM Ca2q. The channel was activated by
micromolar Ca2q and inactivated by concentrations
above 30 mM Ca2q. Threshold activation of skeletal
and cardiac channels in 50r250 mM transrcis
CsCH SO both fall in the range 0.1–10 mM Ca2q3 3
w x20,58 . In contrast, the skeletal channel was in aver-
age 20-fold more sensitive to inactivation by high
w 2qxCa than the cardiac channel, with threshold inhi-
w xbitions of 100 mM and 1–2 mM, respectively 20,58 .
Thus, the sensitivity of the diaphragm SR Ca2q-re-
w 2qxlease channel to high Ca is similar to that of the
skeletal SR channel.
Micromolar Ca2q concentrations significantly in-
w3 xcreased H rya-nodine binding to the diaphragm and
 .cardiac SR Fig. 4C . Diaphragm SR was less sensi-
tive to Ca2q than cardiac SR. The threshold for
detection of ryanodine binding was around 5 mM
Ca2q for the diaphragm, compared to less than 0.3
mM Ca2q for the cardiac SR. Half-maximal binding
 .EC was reached with 40.0 mM and 3.5 mM free50
Ca2q, respectively. Similar Ca2q-dependent
w3 xH ryano-dine binding relationships have been re-
ported in the literature for the cardiac SR Ca2q-re-
lease channel, with half-maximal binding around 1
2q w xmM Ca 52,47 . In contrast, Zimanyi and Pessah
w x62 demonstrated that ryanodine binding was less
sensitive to Ca2q in skeletal SR than in cardiac SR,
with EC values of 50 and 1 mM, respectively.50
These results also support a similar Ca2q sensitivity
for the diaphragm and skeletal SR membranes.
3.4. Acti˝ation by ATP and inhibition by Mg 2q
The modulating effects of ATP and Mg2q on the
diaphragm SR Ca2q-release channel are illustrated in
Fig. 5A. Channel fusions were initially performed in
50r250 mM transrcis CsCH SO and 1 mM free3 3
Ca2q. Under these conditions, the channel displayed
a relatively low activity characterized by short open
 .events F10 ms . The channel was maximally acti-
vated by addition of 2 mM ATP to the cis chamber.
Then, Mg2q modified the channel activity and gating
in a manner which was similar to that reported for
2q w xother SR Ca -release channels 18 . With increasing
w 2qxMg , long open events were gradually replaced by
very brief events separated by long closed events.
The fact that Mg2q induced a rapid flickering of
Ca2q- and ATP-activated channels suggests that the
w xcation may partially obstruct the pore 15 . Fig. 5B
summarizes the effect of Mg2q on the channel P . Ao
sigmoid relationship was obtained by plotting
steady-state P values against the logarithm of freeo
w 2qx  .Mg cis. The 50% inhibitory concentration IC50
was estimated at 100 mM Mg2q, and complete chan-
nel inactivation was observed with 3 mM Mg2q.
Similarly, 3 to 5 mM free Mg2q was shown to
prevent Ca2q activation and to depress P ino
2q w xCa rATP-activated skeletal channels 63 . Cardiac
SR Ca2q-release channels were reported to be less
sensitive to Mg2q than skeletal SR channels, with
threshold inhibition and IC values of approximately50
w x0.3 and 1 mM, respectively 56 .
We also compared the effect of Mg2q on the
w3 xbinding of nanomolar H ryanodine to the di-
2q  .Fig. 4. Calcium sensitivity of the Ca -release channel activity and ryanodine binding to the diaphragm SR. A Unitary current
 .recordings measured at a holding potential of q50 mV in 50r250 mM transrcis CsCH SO , 20 mM Tris–HEPES pH 7.4 and3 3
2q  .increasing concentrations of free Ca in the cis chamber. Arrowheads on the right indicate the zero-current level. B Concentration-re-
2q  .sponse curve of the effects of free Ca cis on the diaphragm channel open probability P , performed under the experimentalo
 . 2qconditions described above. Data points represent average values "SEM from four or five experiments. Free Ca concentrations were
w x  . w3 x  .calculated by a computer program provided by Dr. Fabiato 43 . C Percent H ryanodine binding to the diaphragm DIA and cardiac
 . 2q  .  .CM SR membrane enriched fractions as a function of free Ca concentration ns4 . Average values "SEM were expressed in
percent of maximum binding capacity: 1.2 pmolrmg protein for the diaphragm and 2.2 pmolrmg protein for the cardiac SR membranes.
Ryanodine binding was less sensitive to Ca2q in diaphragm SR than in cardiac SR.
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2q  .Fig. 5. Magnesium sensitivity of the Ca -release channel activity and ryanodine binding to the diaphragm SR. A Unitary current
recordings measured at a holding potential of q60 mV in 50r250 mM transrcis CsCH SO ,1 mM free Ca2q and 20 mM Tris–HEPES3 3
 .  .pH 7.4 . Under these conditions, channel activity was minimal first trace . The channel was activated by addition of 2 mM Na ATP cis2
 . 2q  .  .second trace and then inhibited by sequential addition of 0 to 300 mM free Mg to the cis chamber lower traces . B
Concentration-dependent effects of free Mg2q cis on the P of the diaphragm channel, performed under the experimental conditionso
 .  . w3 xdescribed above. Data points represent average values "SEM from six experiments. C Normalized percent H ryanodine binding to
 .  .  . 2q  .the native diaphragm B , skeletal ’ and cardiac v SR Ca -release channels as a function of MgSO concentration ns4 .4
 . Average values "SEM were expressed in percent of the maximum binding capacity for each preparation 1.2, 2.2 and 3.5 pmolrmg
. w3 xprotein for the diaphragm, cardiac and skeletal SR membranes, respectively . Note that H ryanodine binding to the diaphragm and
skeletal muscle SR channels decreased with increasing concentration, but this was not the case for the cardiac SR.
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 .aphragm, skeletal and cardiac SR Fig. 5C .
w3 xH ryanodine binding to the diaphragm and skeletal
channels gradually decreased with increasing concen-
trations of Mg2q, with IC values estimated at 5 and50
2q w3 x3 mM Mg , respectively. In contrast, H ryanodine
binding to the cardiac channel remained above 90%
with Mg2q concentrations as high as 10 mM. In the
w3 xliterature, H ryanodine binding to the cardiac chan-
nel was also found to be less sensitive to Mg2q than
w xthe skeletal channel 17,18,62 . Therefore, based on
Mg2q sensitivity, the diaphragm channel would be
classified as a skeletal isoform.
3.5. Inhibition of the Ca2q-release channel by
micromolar ryanodine
Fig. 6 shows the behavior of a single channel
recorded in 50r250 mM transrcis CsCH SO and 13 3
Fig. 6. Effect of ryanodine on the diaphragm SR Ca2q-release channel. Unitary current recordings measured at a holding potential of q60
2q  .mV in 50r250 mM transrcis CsCH SO , 1 mM free Ca , 20 mM Tris–HEPES at pH 7.4 upper trace . The channel was maximally3 3
 .activated by 2 mM Na ATP cis middle trace . Within 1–2 min after addition to the cis chamber, ryanodine blocked the channel into a2
 .subconducting state lower trace .
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Fig. 7. Analysis of protein fractions collected from the sucrose
 . w3 xgradient used to purify the ryanodine receptor. A H ryanodine
sedimentation profile following centrifugation of solubilized SR
membranes on a 5–25% sucrose gradient. The open symbols
indicate the percent sucrose determined in the corresponding
 .  . w3 xfractions. v Total and non-specific B H ryanodine binding.
w3 xNotice the absence of specific H ryanodine binding in fractions
 .  .11 and 12 in the presence of excess cold ryanodine 5 mM . B
 .SDS-PAGE analysis of SR membranes SR , SR membranes
 ).solubilized SR and fractions collected from the sucrose gradi-
ents prior to and following solubilization and purification of the
ryanodine receptor. Equal amounts of proteins were subjected to
SDS-PAGE on a 6% gel and stained with Coomassie blue.
Molecular weight standards and the f400 kDa ryanodine recep-
 .tor RR are indicated by arrowheads.
Fig. 8. Comparative immunoblot analysis of the protein profiles
of cardiac, skeletal and diaphragm muscle SR membranes. Mi-
 .  .crosomal fractions isolated from canine soleus Sol , heart Heart ,
 .  .diaphragm Dia and rabbit white skeletal WSK muscles were
subjected to SDS-PAGE and transferred to nitro-cellulose mem-
branes. Immuno-staining was performed with skeletal anti-RyR1
 .polyclonal antibodies Section 2 . On the right are shown the
negative controls performed on canine cardiac and diaphragm SR
fractions in the absence of primary antibody. Arrows and num-
 .bers represent the positions and the values kDa of the molecular
weight standards, respectively. The skeletal anti-RyR antibodies1
reacted with a ;400 kDa protein band in the diaphragm, soleus
and WSK SR membranes.
mM free Ca2q. Under these conditions, the channel
 .activity was very low P s0.02 , characterized byo
spike-like openings. The channel was activated by 2
 .mM ATP cis P s0.87 and then inhibited by 20o
mM ryanodine cis. Within 1–2 min after addition of
ryanodine to the cis chamber, the channel was
blocked into a subconductance state. Similar modifi-
cations were reported for skeletal and cardiac SR
2q w xCa -release channels 64 .
Fig. 9. Biophysical properties and electrophysiological characterization of the purified diaphragm SR ryanodine receptor reconstituted into
 . 2qplanar lipid bilayers. A Single channel activity recorded at various holding potentials in symmetrical 200 mM KCl, 100 mM free Ca ,
 .  .20 mM K–HEPES pH 7.4 and 1 mM Na ATP cis. B Currentrvoltage relationships in 200r200 mM and 200r300 mM transrcis2
 .  .KCl, with respective mean "SEM conductances of 703"15 pS and 727"21 pS ns3 . The reversal potential was shifted toward the
 .  .calculated equilibrium potential in asymmetrical buffer systems. C Average P values "SEM as a function of the applied voltage foro
 . 2q  .the purified ryanodine receptor v and the native Ca -release channel B , measured in symmetrical 200 mM KCl, 20 mM K–HEPES
 . 2q  .pH 7.4 , plus 100 mM free Ca and 2 mM Na ATP cis and in 50r250 mM transrcis CsCH SO , 20 mM Tris–HEPES pH 7.4 , plus2 3 3
2q  .10 mM free Ca and 2 mM Na ATP cis, respectively ns5 . Open probability values increased from 0.6 to 1.0 with depolarizing2
voltages.
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3.6. Purification of the diaphragm SR Ca2q-release
channel
The Ca2q-release channel was solubilized from SR
membrane vesicles with 1% CHAPS and 3% Azolec-
 2qtine 1 M NaCl, 5 mM AMP, 50 mM free Ca and
w3 x .170 nM H ryanodine , and purified by ultracentrifu-
 .gation in a linear 5–25% wrv sucrose density
gradient. The resulting fractions, as well as solubi-
w3 xlized SR membranes, were analyzed for H ryano-
dine binding activity and protein content. A single
peak of radioactivity was detected in 17–19% su-
 .crose Fig. 7A , as previously determined for the
w xcardiac and skeletal SR membranes 7,12 . Radioac-
tivity in fractions 15–20 was decreased close to the
background level when the solubilized membranes
were incubated with 5 mM cold ryanodine. The large
amount of radioactivity at the top of the gradient
w3 xcorresponded to unbound H ryanodine. SDS-PAGE
analysis indicated specific comigration of a single
high molecular weight polypeptide of ;400 kDa in
the SR microsomal fractions before and after solubi-
lization. This protein band was only detected in the
w3 x  .H ryanodine binding fractions, 11 and 12 Fig. 7B .
The 400 kDa protein has been previously identified
as the monomeric component of the Ca2q-release
Fig. 10. Ruthenium red inhibition of the purified and reconstituted diaphragm SR Ca2q channel. Single channel activity recorded in
 . 2qsymmetrical 200 mM KCl, 20 mM K-HEPES pH 7.4 , 100 mM free Ca and 1 mM Na ATP cis, at a holding potential of q40 mV.2
 .  .  .A Control channel activity in the absence of ruthenium red. B Partial inhibition of the current with 10 mM ruthenium red cis. C The
channel activity was further inhibited by 20 mM ruthenium red cis. Complete inhibition occurred 25 s after the addition of ruthenium red
 X.  X.  X.20 mM cis. A , B and C are corresponding amplitude histograms from 1 min data files. P values represent the fraction of timeo
spent by the channel in the fully-open and subconducting states.
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w xchannel 12 . Minor contaminations, probably by the
205 kDa myosin and the 160–176 kDa a - and1
a -subunits of the dihydropyridine receptor, were2
occasionally detected in fractions 11 and 12, in which
cases the protein fraction was further purified on a
w xheparine-sepharose affinity column 47 . Most of the
other SR proteins, such as the 100 kDa Ca2q, Mg2q-
w x w xATPase 65 andror triadin 66 , remained at the top
portion of the sucrose density gradient.
The identity of the purified protein was further
assessed with a polyclonal antibody raised against the
 .skeletal RyR isoform provided by Dr. Meissner .1
Membrane fractions were prepared from canine
slow-twitch soleus muscles, heart, diaphragm, and
 .rabbit fast-twitch white skeletal WSK muscles, as
described in Section 2. The antibody recognized a
;400 kDa protein band in the diaphragm, the slow-
twitch soleus and in fast-twitch WSK muscles, but
 .not in cardiac muscles Fig. 8 . Additional protein
bands which migrated at ;300 and ;200 kDa were
occasionally detected. Most likely their appearance
was due to partial degradation of the ;400 kDa
w xband by endogenous proteases 12,67 .
3.7. Biophysical properties of the purified
Ca2q-release channel
 .The purified diaphragm ryanodine receptor RyR ,
added to the cis chamber, incorporated itself into the
PLB in such a way that the regulatory sites located
on the cytoplasmic side of the channel are exposed to
the cis chamber. In all reconstitution experiments, the
purified complex was incorporated in symmetrical
200 mM KCl, 20 mM K–HEPES, 10 or 100 mM free
Ca2q and 1–2 mM ATP cis. The choice of buffer
was motivated by the finding that symmetrical mono-
valent buffer systems facilitate reconstitution of
skeletal and cardiac purified RyR, and that larger
unitary currents were recorded with Kq or Naq than
2q w xwith Ca as the permeant cation 7,12,54,60 . Fig.
9A shows typical unitary current recordings of a
RyR, characterized by the predominance of long open
states with frequent incomplete transitions into the
w xclosed state 10 . The channels displayed an ex-
 .tremely high conductance 714"22 pS , as reported
w x w xfor cardiac 68,69 and skeletal isoforms 68,70 in
250 mM KCl. The shift in reversal potential toward
negative voltages in 200r300 mM transrcis KCl
argues in favor of a cation selectivity with respect to
y  .Cl anions Fig. 9B . Thus, the purified canine di-
aphragm RyR functions as a cation-selective channel
following reconstitution into PLB, as previously
w xshown for the purified skeletal RyR 12,54 .
Voltage sensitivity of the native and purified di-
aphragm SR Ca2q-release channels were compared
over the same range of potentials in the presence of
symmetrical 10 mM free Ca2q and 1 mM ATP cis.
The native and purified channels displayed similar
low voltage dependency, P values increasing fromo
 .0.5 to 0.9 with depolarizing voltages Fig. 9C .
w xRousseau and Meissner 19 reported P values in-o
creasing from 0.25 to 0.65 at voltages from y40 to
q20 mV, with 2.5 mM cytoplasmic free Ca2q and
50 mM Ca2q trans as the permeant ion. The lower
P values would be explained by the absence of ATPo
w xin their buffers 18,19,41,71 .
3.8. Inhibition of the purified Ca2q-release channel
by ruthenium red
We examined the gating behavior and P of theo
purified diaphragm RyR reconstituted in PLB follow-
ing the addition of micromolar ruthenium red.
Single-channel fluctuations were initially recorded in
200 mM KCl, 100 mM free Ca2q and 1 mM ATP cis
 .Fig. 10A . Addition of 10 mM ruthenium red to the
cis chamber did not affect the channel conductance,
but long closed events and subconductance states of
about half-maximal conductance were frequently ob-
 .served Fig. 10B . The channel P decreased fromo
 X.  X.0.73 Fig. 10A to 0.25 Fig. 10B . Complete and
irreversible inhibition of the channel activity was
obtained with 20 mM ruthenium red within 25 s Fig.
X.10C and C . In the literature, 1 to 30 mM ruthenium
red were also shown to completely abolish the activ-
ity of both native and purified cardiac and skeletal
w xchannels in PLB 7,12,41,56 .
4. Discussion
Electrical coupling between surface membrane de-
polarization and SR Ca2q release in skeletal and
cardiac muscles involves two different mechanisms.
In cardiac muscle, extracellular Ca2q enters through
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voltage-sensitive DHPRs located in the T-tubules and
activates SR RyRs, a mechanism referred to as
2q 2q w xCa -induced Ca release 25 . In skeletal muscle,
the DHPRs would be ‘physically’ linked to the RyRs,
an activation independent of extracellular Ca2q entry
w x23,24 . Although classified as a skeletal muscle, the
diaphragm appears to be functionally closer to the
myocardium. They both contract rhythmically for
life, and extracellular Ca2q plays an important role in
w xforce generation 72 . These particularities could in-
volve differences in the ECC machinery of the di-
aphragm, compared to other skeletal muscles.
In this study, we describe the biochemical and
biophysical properties of the native and purified di-
aphragm SR Ca2q-release channel. Ryanodine, the
2q w xspecific marker of SR Ca -release channels 3,4 ,
was shown to bind to diaphragm SR membranes with
K and B values similar to those of cardiac andD max
w xskeletal SR 13,21,47–50 . Incorporation of SR vesi-
cles into PLB yielded large conductance Csq cur-
rents, which were affected by the same factors that
modulate the Ca2q-release channels of cardiac and
skeletal SR, namely ryanodine, Ca2q, Mg2q and
w xATP 15 . The channel was purified as a 400 kDa
protein on SDS-PAGE, a band previously identified
as the monomeric component of the RyR in rabbit
w xskeletal muscle 12 . Reconstitution of the purified
channel into PLB yielded current conductances above
700 pS in KCl, as reported for the other isoforms
w x54,55 . The purified channel exhibited gating proper-
ties typical to RyRs, retained the P rvoltage depen-o
dence of the native channel and was inhibited by
w xmicromolar ruthenium red 15 .
We provide evidence that the properties of the
diaphragm SR Ca2q-release channel correspond
closely to those of skeletal muscle RyRs. First, the
w3 xIC of H ryanodine binding to diaphragm SR by50
ryanodine was within the range reported for skeletal
 . w x SR 18–22 nM 10 , but higher than the IC 5.250
. w xnM reported for cardiac SR 39 . Second, EC for50
ryanodine binding to diaphragm SR was reached with
40 mM Ca2q, which is in the range as reported for
w xskeletal SR 62 , but higher than values estimated for
 . cardiac SR in this study 3.5 mM and elsewhere 1
. w xmM 47,52 . Third, ryanodine binding sensitivity to
millimolar Mg2q was higher for the diaphragm and
w xskeletal SR than for cardiac SR 17,18,62 . The chan-
nel sensitivity to Ca2q and Mg2q in PLB corrob-
orated these findings. Threshold inhibition by cyto-
plasmic Ca2q was 30–100 mM, which is in the same
range of skeletal isoform, but 20-fold lower than
w x 2qreported for the cardiac channel 20,58 . And Ca
release was completely abolished by 3–5 mM Mg2q,
w xas reported for skeletal channels 63 . Therefore,
based on ryanodine-binding and gating properties, the
diaphragm would be classified as a skeletal muscle.
The data presented in this study could not account
for the high sensitivity of diaphragm muscle contrac-
tion to extracellular Ca2q. However, recent findings
on the distribution of the different RyR isoforms in
vertebrates suggest that ECC may be far more sophis-
ticated than anticipated from current recordings of
cardiac and skeletal channels in PLB, or 45Ca2q-
loaded SR vesicles. Until recently, it was generally
believed that mammalian tissues express a cardiac
 .  .isoform RyR , a skeletal isoform RyR and a2 1
 .brain isoform also present in smooth muscles RyR .3
More sensitive mRNA techniques and isoform-
specific antibodies have allowed the detection of
more than one isoform in most tissues, including
w xmuscles, glands and the brain 73,74 . Cardiac mus-
cles express RyR and RyR , whereas skeletal mus-2 3
w xcles express RyR and RyR 74 . In skeletal mus-1 3
cles, while RyR was expressed at high levels, RyR1 3
w xcontent was found highly variable 75 . This isoform
was more abundant in the diaphragm and soleus than
in the tibialis anterior and abdominal muscles and no
RyR was detected in fast-twitch extensor digitorum3
 .longus EDL . Interestingly, the relative content of
skeletal muscles in RyR reflects their sensitivity to3
extracellular Ca2q. Twitch tension of diaphragm and
cardiac muscle fibers was abolished 3 and 10 min
after removal of extracellular Ca2q, respectively. In
contrast, twitch tension of soleus and EDL muscles
were at 62 and 75% of control fibers after a 30 min
2q w xzero-Ca exposure 72 . These findings suggest that
RyR could be involved in SR Ca2q-induced Ca2q3
release. In support of this, ultrastructural and ligand
binding studies indicate that in skeletal muscles, not
w xall RyRs are mechanically coupled to DHPRs 2,15 .
Mice that carry a null mutation for the RyR gene1
lack electrical coupling in their skeletal myocytes
w x76 . These cells still responded to caffeine by SR
Ca2q release equivalent to one-tenth of the level
measured in normal mice, which probably corre-
w xsponded to the activity of RyR 76 . Therefore,3
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RyR would be coupled to DHPRs, while RyR1 3
would be Ca2q-gated Ca2q channels. A similar hy-
pothesis was drawn by comparing cDNA sequences
of mammalian and nonmammalian RyRs. The
‘skeletal-like’ a-isoform and the ‘cardiac-like’ b-iso-
form of frog and chicken skeletal muscles were found
most homologous to RyR and RyR isoforms, re-1 3
w xspectively 77,78 .
The two RyR isoforms expressed in skeletal mus-
cles have not been distinguished so far on the basis of
w xelectrophysiological properties 1,2,15 . A possible
explanation would be that the ratio of RyR rRyR is3 1
too low for RyR to be detected and identified in3
PLB. However, it is unlikely to be the case for the
diaphragm, where RyR was found particularly abun-3
dant. An alternative explanation would be that the
two isoforms coexist in RyR heterotetramers, and that
the biophysical properties of the SR Ca2q-release
channel recorded in PLB represent the overall contri-
bution of the two isoforms. The mechanism by which
voltage-gated and Ca2q-gated RyRs may interact has
w xbeen investigated by Klein et al. 79 using voltage-
clamp and confocal imaging techniques on frog
skeletal muscles. They proposed that a local rise in
Ca2q concentration generated by the voltage-gated
a-RyRs would activate nearby ligand-gated b-RyRs,
giving rise to a stochastic pattern of Ca2q-release
events. Yet the existence of a similar mechanism in
mammalian tissues is being questioned, since RyR3
is often expressed in much lower level than RyR .1
Whether they exist as homotetramers or heterote-
tramers, they would have to be restricted to specific
regions of SR membranes in order to play a signifi-
cant role in ECC. Further studies are warranted to
elucidate the functional implications of mixed popu-
lations of RyRs in ECC of mammalian skeletal mus-
cles as vital as the diaphragm.
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